Bio-Rad rolls out SARS CoV-2 standards for Coronavirus Testing
Category: #health  By Nikita Chaurasia  Date: 2020-03-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

Bio-Rad rolls out SARS CoV-2 standards for Coronavirus Testing
  • The SARS CoV-2 standard has human genomic DNA and synthetic COVID-19 RNA transcripts.
     
  • SARS CoV-2 standard assists laboratories to keep up with the soaring demand for the identification of Coronavirus by helping validate COVID-19 tests.

Amidst the unprecedented fear of Coronavirus (COVID-19), Bio-Rad Laboratories, Inc. has announced the launch of a SARS CoV-2 standard to underpin laboratory assay validation of COVID-19 testing. The testing will be part of its Exact Diagnostics product line as the company is offering the SARS CoV-2 standard to aid labs to expedite access to testing and authenticate their COVID-19 assay results.

The SARS CoV-2 standard has human genomic DNA and synthetic COVID-19 RNA transcripts, thereby enabling laboratories to test the total process of a molecular assay such as amplification, extraction and detection of the virus.

It is worth noting that the (CLIA) Clinical Laboratory Improvement Amendments federal regulatory standards need clinical laboratories to document and build their own specifications of performance meant for test developed in laboratory to make precise and accurate results before the test is implemented.

Dara Wright, Bio-Rad Executive Vice President, highlighted the significance of labs to have access to aptly-defined standards to assist with the authentication of the tests in case of a public health emergency.

Wright stressed that the SARS CoV-2 standard assists laboratories to keep up with the soaring demand for the identification of Coronavirus by helping validate COVID-19 tests.

The press release shared by Bio-Rad states that the Exact Diagnostics product line develops and manufactures an array of innovatively designed molecular diagnostics products to keep abreast with the needs of quality control of assay manufacturers and clinal labs.

Underpinned by offering quality products and services to labs and manufacturers, the diagnostic products intend to improve patient care by helping to assure the validity of screening tests and diagnostic results.

Source credit:

https://www.bio-rad.com/en-in/corporate/newsroom/bio-rad-announces-that-through-its-exact-diagnostics-product-line-company-has-launched-sars-cov-2-standard-for-coronavirus-covid-19-testing?ID=Bio-Rad-Announces-th_1584057675

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Breast cancer: New treatment claims to reduce recurrence risk by 25%
Breast cancer: New treatment claims to reduce recurrence risk by 25%
By Nikita Chaurasia

  The research comprised of patients with increased cellular proliferation and larger tumor size monarchE trials were funded by Eli Lilly and Co. and led by Royal Marsden NHS Foundation Trust Reportedly, the phase three monarchE trial has ...

Todos, NCL Pharma adds NLC-001 dietary supplement to its joint venture
Todos, NCL Pharma adds NLC-001 dietary supplement to its joint venture
By Nikita Chaurasia

Todos Medical Ltd., an Israeli in-vitro diagnostic company based, recently announced that NLC Pharma, Inc., its joint venture partner, has added the NLC-001 dietary supplement to their COVID-19 focused-partnership. This will reportedly grant Todos th...

Airlines and labor unions request USD 25 billion more in federal aid
Airlines and labor unions request USD 25 billion more in federal aid
By Nikita Chaurasia

Airline CEOs and labor unions have reportedly requested for additional USD 25 billion in federal aid amidst the rising concerns of more than 30,000 jobs being at stake. Sources with relevant information stated that airline executives are soon plannin...